CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

NCT01985828 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Wake Forest University Health Sciences